Goldman Sachs warns a vaccine-resistant COVID-19 strain could cut US growth by more than a third in 2021

Goldman Sachs warns a vaccine-resistant COVID-19 strain could cut US growth by more than a third in 2021

Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Close icon Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification. Account active since The emergence of a vaccine-resistant strain of coronavirus would have the potential to derail the US economic recovery, Goldman Sachs said in a report, laying out possible risks to the outlook in 2021. Goldman economists said in a note over the weekend they still believed vaccinations and government support will lead to "very strong growth" in 2021. Almost all investors agree, which has driven stock markets to all-time highs in recent weeks. But the bank said a few - albeit unlikely - events could cause a "much slower recovery" that could see the economy grow just 4% in 2021 rather than 6. 6%, as the bank currently expects. They are: Consumers remaining more cautious than economists expect; virus mutations raising the bar for "herd immunity"; and the evolution of a vaccine-resistant strain of COVID-19.